Alterity Therapeutics (ATHE) Stock Off Session High: Gets New Patent
A biotechnology company developing disease-modifying treatments for neurodegenerative conditions, Alterity Therapeutics (NASDAQ:ATHE) on August 4, 2021 announced the United States Patent and Trademark Office issuing Notice of Allowance for Alterity’s patent application No. 17/239,375. This would secure exclusivity for a fresh group of iron chaperones made for redistributing the excess iron in many neurodegenerative diseases, including Parkinson’s and Alzheimer’s. The patent, which is titled “Compounds for and Methods of Treating…